IBDEI0RR ; ; 01-FEB-2022
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,12495,0)
 ;;=R39.2^^49^603^26
 ;;^UTILITY(U,$J,358.3,12495,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12495,1,3,0)
 ;;=3^Extrarenal Uremia
 ;;^UTILITY(U,$J,358.3,12495,1,4,0)
 ;;=4^R39.2
 ;;^UTILITY(U,$J,358.3,12495,2)
 ;;=^5019348
 ;;^UTILITY(U,$J,358.3,12496,0)
 ;;=R30.1^^49^603^57
 ;;^UTILITY(U,$J,358.3,12496,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12496,1,3,0)
 ;;=3^Vesical Tenesmus
 ;;^UTILITY(U,$J,358.3,12496,1,4,0)
 ;;=4^R30.1
 ;;^UTILITY(U,$J,358.3,12496,2)
 ;;=^5019323
 ;;^UTILITY(U,$J,358.3,12497,0)
 ;;=Z85.46^^49^603^28
 ;;^UTILITY(U,$J,358.3,12497,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12497,1,3,0)
 ;;=3^Hx of Malig Neop of Prostate
 ;;^UTILITY(U,$J,358.3,12497,1,4,0)
 ;;=4^Z85.46
 ;;^UTILITY(U,$J,358.3,12497,2)
 ;;=^5063423
 ;;^UTILITY(U,$J,358.3,12498,0)
 ;;=N18.1^^49^603^7
 ;;^UTILITY(U,$J,358.3,12498,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12498,1,3,0)
 ;;=3^Chr Kidney Disease,Stage 1
 ;;^UTILITY(U,$J,358.3,12498,1,4,0)
 ;;=4^N18.1
 ;;^UTILITY(U,$J,358.3,12498,2)
 ;;=^5015602
 ;;^UTILITY(U,$J,358.3,12499,0)
 ;;=N18.2^^49^603^8
 ;;^UTILITY(U,$J,358.3,12499,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12499,1,3,0)
 ;;=3^Chr Kidney Disease,Stage 2
 ;;^UTILITY(U,$J,358.3,12499,1,4,0)
 ;;=4^N18.2
 ;;^UTILITY(U,$J,358.3,12499,2)
 ;;=^5015603
 ;;^UTILITY(U,$J,358.3,12500,0)
 ;;=N18.4^^49^603^12
 ;;^UTILITY(U,$J,358.3,12500,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12500,1,3,0)
 ;;=3^Chr Kidney Disease,Stage 4
 ;;^UTILITY(U,$J,358.3,12500,1,4,0)
 ;;=4^N18.4
 ;;^UTILITY(U,$J,358.3,12500,2)
 ;;=^5015605
 ;;^UTILITY(U,$J,358.3,12501,0)
 ;;=N18.5^^49^603^13
 ;;^UTILITY(U,$J,358.3,12501,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12501,1,3,0)
 ;;=3^Chr Kidney Disease,Stage 5
 ;;^UTILITY(U,$J,358.3,12501,1,4,0)
 ;;=4^N18.5
 ;;^UTILITY(U,$J,358.3,12501,2)
 ;;=^5015606
 ;;^UTILITY(U,$J,358.3,12502,0)
 ;;=N18.6^^49^603^17
 ;;^UTILITY(U,$J,358.3,12502,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12502,1,3,0)
 ;;=3^ESRD
 ;;^UTILITY(U,$J,358.3,12502,1,4,0)
 ;;=4^N18.6
 ;;^UTILITY(U,$J,358.3,12502,2)
 ;;=^303986
 ;;^UTILITY(U,$J,358.3,12503,0)
 ;;=N18.9^^49^603^14
 ;;^UTILITY(U,$J,358.3,12503,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12503,1,3,0)
 ;;=3^Chr Kidney Disease,Unspec
 ;;^UTILITY(U,$J,358.3,12503,1,4,0)
 ;;=4^N18.9
 ;;^UTILITY(U,$J,358.3,12503,2)
 ;;=^332812
 ;;^UTILITY(U,$J,358.3,12504,0)
 ;;=N17.8^^49^603^2
 ;;^UTILITY(U,$J,358.3,12504,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12504,1,3,0)
 ;;=3^Acute Kidney Failure,Other
 ;;^UTILITY(U,$J,358.3,12504,1,4,0)
 ;;=4^N17.8
 ;;^UTILITY(U,$J,358.3,12504,2)
 ;;=^5015601
 ;;^UTILITY(U,$J,358.3,12505,0)
 ;;=N25.89^^49^603^29
 ;;^UTILITY(U,$J,358.3,12505,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12505,1,3,0)
 ;;=3^Impaired Renal Tubular Function Disorder NEC
 ;;^UTILITY(U,$J,358.3,12505,1,4,0)
 ;;=4^N25.89
 ;;^UTILITY(U,$J,358.3,12505,2)
 ;;=^5015618
 ;;^UTILITY(U,$J,358.3,12506,0)
 ;;=N27.1^^49^603^54
 ;;^UTILITY(U,$J,358.3,12506,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12506,1,3,0)
 ;;=3^Small Kidney,Bilateral
 ;;^UTILITY(U,$J,358.3,12506,1,4,0)
 ;;=4^N27.1
 ;;^UTILITY(U,$J,358.3,12506,2)
 ;;=^5015624
 ;;^UTILITY(U,$J,358.3,12507,0)
 ;;=N20.1^^49^603^6
 ;;^UTILITY(U,$J,358.3,12507,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12507,1,3,0)
 ;;=3^Calculus of Ureter
 ;;^UTILITY(U,$J,358.3,12507,1,4,0)
 ;;=4^N20.1
